Exploring the Complexity of the HIV-1 Fitness Landscape
暂无分享,去创建一个
Sebastian Bonhoeffer | Christos J. Petropoulos | Gabriel E. Leventhal | Roger D. Kouyos | Trevor Hinkley | Jeannette M. Whitcomb | C. Petropoulos | S. Bonhoeffer | T. Hinkley | R. Kouyos | G. Leventhal | J. Whitcomb | Mojgan Haddad | M. Haddad
[1] Weinberger,et al. RNA folding and combinatory landscapes. , 1993, Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics.
[2] M. Whitlock,et al. FACTORS AFFECTING THE GENETIC LOAD IN DROSOPHILA: SYNERGISTIC EPISTASIS AND CORRELATIONS AMONG FITNESS COMPONENTS , 2000, Evolution; international journal of organic evolution.
[3] D. Richman,et al. 2022 update of the drug resistance mutations in HIV-1. , 2022, Topics in antiviral medicine.
[4] A. Ferré-D’Amaré,et al. Rapid Construction of Empirical RNA Fitness Landscapes , 2010, Science.
[5] Yves Moreau,et al. Estimation of an in vivo fitness landscape experienced by HIV-1 under drug selective pressure useful for prediction of drug resistance evolution during treatment , 2008, Bioinform..
[6] L. Bourgon,et al. Selection and characterization of HIV-1 showing reduced susceptibility to the non-peptidic protease inhibitor tipranavir. , 2005, Antiviral research.
[7] Joachim Krug,et al. Evolutionary Accessibility of Mutational Pathways , 2011, PLoS Comput. Biol..
[8] J. Noel,et al. Quantitative exploration of the catalytic landscape separating divergent plant sesquiterpene synthases , 2008, Nature chemical biology.
[9] M. Kimura,et al. The neutral theory of molecular evolution. , 1983, Scientific American.
[10] M. Wainberg,et al. Protease inhibitor resistance in HIV-infected patients: molecular and clinical perspectives. , 2007, Antiviral research.
[11] E. Weinberger,et al. Correlated and uncorrelated fitness landscapes and how to tell the difference , 1990, Biological Cybernetics.
[12] Erik van Nimwegen,et al. Influenza Escapes Immunity Along Neutral Networks , 2006 .
[13] P. Schuster,et al. IR-98-039 / April Continuity in Evolution : On the Nature of Transitions , 1998 .
[14] B. Calcott. Fitness Landscapes and the Origin of Species , 2005 .
[15] P. Keightley,et al. Interference among deleterious mutations favours sex and recombination in finite populations , 2006, Nature.
[16] N. Barton,et al. SELECTION FOR RECOMBINATION IN SMALL POPULATIONS , 2001, Evolution; international journal of organic evolution.
[17] Sebastian Bonhoeffer,et al. A systems analysis of mutational effects in HIV-1 protease and reverse transcriptase , 2011, Nature Genetics.
[18] Huldrych F. Günthard,et al. Assessing Predicted HIV-1 Replicative Capacity in a Clinical Setting , 2011, PLoS pathogens.
[19] P. Schuster,et al. Statistics of RNA secondary structures , 1993, Biopolymers.
[20] Elijah Paintsil,et al. Competitive Fitness of Nevirapine-Resistant Human Immunodeficiency Virus Type 1 Mutants , 2004, Journal of Virology.
[21] S. Wright,et al. Evolution in Mendelian Populations. , 1931, Genetics.
[22] D. J. Kiviet,et al. Empirical fitness landscapes reveal accessible evolutionary paths , 2007, Nature.
[23] S. Kauffman,et al. Towards a general theory of adaptive walks on rugged landscapes. , 1987, Journal of theoretical biology.
[24] Nigel F. Delaney,et al. Darwinian Evolution Can Follow Only Very Few Mutational Paths to Fitter Proteins , 2006, Science.
[25] Erik van Nimwegen,et al. Epidemiology. Influenza escapes immunity along neutral networks. , 2006, Science.
[26] M. Whitlock,et al. FACTORS AFFECTING THE GENETIC LOAD IN DROSOPHILA: SYNERGISTIC EPISTASIS AND CORRELATIONS AMONG FITNESS COMPONENTS , 2000, Evolution; international journal of organic evolution.
[27] Stephen P. Miller,et al. The Biochemical Architecture of an Ancient Adaptive Landscape , 2005, Science.
[28] Elizabeth C. Theil,et al. Epochal Evolution Shapes the Phylodynamics of Interpandemic Influenza A (H3N2) in Humans , 2006, Science.
[29] D. Richman,et al. Update of the drug resistance mutations in HIV-1: December 2010. , 2010, Topics in HIV medicine : a publication of the International AIDS Society, USA.
[30] Gary D Bader,et al. The Genetic Landscape of a Cell , 2010, Science.
[31] C. Petropoulos,et al. Evidence for Positive Epistasis in HIV-1 , 2004, Science.
[32] Christos J. Petropoulos,et al. A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1 , 2000, Antimicrobial Agents and Chemotherapy.